PATENT CLAIM ANALYSIS

Application Number: 15753188
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["424", "001890"]

Abstract:
Subject matter of the present invention is PSMA Binding molecules for use in diagnosis and/or imaging of pain. Diagnosis or imaging of pain may be the visualization of the location of the origin of pain and/or the determination of the etiology of pain and/or the determination of the pain intensity and/or the stratification of subjects suffering from pain.

Claim (Index 10):
The PSMA-binding molecule for use in diagnosis or imaging of pain in a subject suffering from pain or in a patient that is suspected to suffer from pain according to  claim 9 , wherein the increased level of enzyme PSMA at said site of pain is detected as intensity of said tracer compound I after administration to said subject and wherein said tracer compound intensity at the site of pain is statistically increased in comparison to a) said tracer compound intensity at the site of an unaffected contralateral site and/or b) to a threshold that has been statistically determined.

Metadata:
- Claim Count in Document: 16.0
- Percentile: 88.0
- Lexical Diversity: 1.875
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15639445', '14715115', '15764316', '14211683', '15385490']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7449629831015392
- 35 USC 102 Novelty (BERT): 0.5261300844062596
- Combined Prediction Score: 0.7230796932320113
- Mean Citation Score: 279.99895000000004
- Max Citation Score: 326.13727
- Similarity Product: 207.7989413691705

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test